Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Accounts Payables (2010 - 2026)

Incyte's (INCY) quarterly Accounts Payables came in at $250.4 million in Q2 2026, up 3.86% YoY from $241.1 million in Q2 2025, and up 9.53% on a QoQ basis from $228.6 million in Q1 2026.

Analysis

Incyte (INCY) Accounts Payables (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Accounts Payables data on file, last reported at $250.4 million in Q2 2026.

  • Quarterly Accounts Payables rose 3.86% year-over-year to $250.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $250.4 million (up 3.86% YoY) and the FY2025 annual result came in at $209.9 million, up 6.32% from the prior year.
  • Accounts Payables rose to $250.4 million in Q2 2026, from $228.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $277.5 million in Q4 2022 to a low of $55.6 million in Q1 2023.
  • A 5-year average of $179.7 million and a median of $175.3 million in 2024 frame the typical range for Accounts Payables.
  • Annual changes were most pronounced in 2023 — Accounts Payables plunged 63.53% — and 2024, when it jumped 195.22%.
  • Tracing INCY's Accounts Payables over 5 years: stood at $277.5 million in 2022, then plunged by 60.51% to $109.6 million in 2023, then surged by 80.17% to $197.5 million in 2024, then rose by 6.32% to $209.9 million in 2025, then grew by 19.27% to $250.4 million in 2026.
  • The last three Accounts Payables figures came in at $250.4 million (Q2 2026), $228.6 million (Q1 2026), and $209.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 250.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 250.40 Mn
Mar 31, 2026 228.62 Mn
Dec 31, 2025 209.94 Mn
Sep 30, 2025 171.93 Mn
Jun 30, 2025 241.09 Mn
Mar 31, 2025 195.54 Mn
Dec 31, 2024 197.47 Mn
Sep 30, 2024 178.71 Mn
Jun 30, 2024 148.17 Mn
Mar 31, 2024 164.24 Mn
Dec 31, 2023 109.60 Mn
Sep 30, 2023 139.41 Mn
Jun 30, 2023 155.54 Mn
Mar 31, 2023 55.63 Mn
Dec 31, 2022 277.55 Mn
Sep 30, 2022 163.18 Mn
Jun 30, 2022 194.77 Mn
Mar 31, 2022 152.55 Mn
Dec 31, 2021 172.11 Mn
Sep 30, 2021 114.51 Mn